Crohn's Disease Clinical Trials in Kansas City, Kansas

4 studies are recruiting for crohn's disease in Kansas City, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

    Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study i…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    University of Kansas Medical Center, Kansas City, Kansas
    Locations
    201 in total
    Run by
    Takeda

    See if you can join NCT06233461 on ClinicalTrials.gov

  2. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinica…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    University of Kansas Medical Center ( Site 5091), Kansas City, Kansas
    Locations
    499 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06430801 on ClinicalTrials.gov

  3. A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

    This is a phase 2, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease. The total study duration is up …

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Investigational Site Number: 8400006, Kansas City, Kansas
    Locations
    78 in total
    Run by
    Sanofi

    See if you can join NCT06958536 on ClinicalTrials.gov

  4. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study duration may be up to 35 …

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    University of Kansas Medical Center-Site Number: 8400110, Kansas City, Kansas
    Locations
    461 in total
    Run by
    Sanofi

    See if you can join NCT07184931 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.